What is NDC 55150-324?

55150-324 is the product NDC for Furosemide, Furosemide 100 mg/10mL injection, solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Furosemide?

204 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Furosemide NDC 55150-324 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-324Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0324Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-324-25	5515003242555150032425	25 VIAL in 1 CARTON (55150-324-25) / 10 mL in 1 VIAL (55150-324-01)Marketed from May 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 100 mg/10mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Eugia US LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212174
Marketing start: May 3, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 55150-324_9bb2ffa4-0891-4197-a970-90b178bbfad9SPL ID 9bb2ffa4-0891-4197-a970-90b178bbfad9SPL set ID 421aa6d5-623b-4dc2-abd5-bb9e7765bf37RxCUI 1719286, 1719290, 1719291UNII 7LXU5N7ZO5UPC 0355150324019, 0355150323012
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150032425 followed by a unit qualifier and the quantity

Package 55150-0324-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. Edema: Furosemide Injection is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide Injection is particularly useful when an agent with greater diuretic potential is desired. Furosemide Injection is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of Furosemide Injection is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-324

What is NDC 55150-324?: 55150-324 is the product NDC for Furosemide, Furosemide 100 mg/10mL injection, solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Furosemide.
What is the active ingredient?: Furosemide.
Who is the labeler?: Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Furosemide?: 204 other product NDCs are listed under this name. See all Furosemide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Furosemide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Furosemide	Furosemide 10 mg/mL	InjectionIntramuscular, Intravenous	Civica, Inc.	72572-275	72572-0275-10
Furosemide	Furosemide 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4679	70518-4679-00
Furosemide	Furosemide 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-033	87441-0033-01
Furosemide	Furosemide 20 mg/1	TabletOral	Coupler LLC	67046-0768	67046-0768-03
Furosemide	Furosemide 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4609	70518-4609-00
Furosemide	Furosemide 40 mg/1	TabletOral	Coupler LLC	67046-1663	67046-1663-03
Furosemide	Furosemide 20 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-832	10135-0832-0110135-0832-1010135-0832-90
Furosemide	Furosemide 40 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-833	10135-0833-0110135-0833-1010135-0833-90
Furosemide	Furosemide 80 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-834	10135-0834-0110135-0834-0510135-0834-90
Furosemide	Furosemide 20 mg/1	TabletOral	Granulation Technology, Inc.	63561-0164	63561-0164-0163561-0164-0263561-0164-09

All 205 Furosemide NDCs

Other NDCs under ANDA 212174

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212174
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 20 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9864
Furosemide	Furosemide 20 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Eugia US LLC	55150-322
Furosemide	Furosemide 40 mg/4mL	Injection, SolutionIntramuscular, Intravenous	Eugia US LLC	55150-323
Furosemide	Furosemide 20 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7236